Ionova Life Science Competitors and Similar CompaniesClear all
Ionova Life Science's competitors and similar companies include Aravive, MaxiVAX, Curis and ADC Therapeutics.
 Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. |  MaxiVAX MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. |  Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. |  ADC Therapeutics ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers. | ||
Founding Date | Founding Date 2016 | Founding Date 2008 | Founding Date 2013 | Founding Date 2000 | Founding Date 2010 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Houston, US HQ | Locations Genève, CH HQ Genève, CH | Locations Lexington, US HQ Lexington, US | Locations Epalinges, CH HQ London, GB New Providence, US |
Employees | Employees N/A | Employees 23 | Employees 5 | Employees 3144% decrease | Employees 1162% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.9 m | Valuation ($) N/A | Valuation ($) 29.4 m | Valuation ($) 295.9 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $9.4m (FY, 2025) | Revenue (est.) $81.4m (FY, 2025) |
Net income | Net income N/A | Net income ($76.3m) (FY, 2022) | Net income N/A | Net income ($7.6m) (FY, 2025) | Net income ($142.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 17.8m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 5m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 17.8m | Total funding raised N/A | Total funding raised $ 8.1m | Total funding raised N/A | Total funding raised $ 526m |
For sources of this data, please see the company profile
View Company Profiles
Aravive
HQ
Houston, US
Employees
23
Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.
View companyMaxiVAX
HQ
Genève, CH
Employees
5
MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer.
View companyCuris
HQ
Lexington, US
Employees
31↓ 44% decrease
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
View companyADC Therapeutics
HQ
Epalinges, CH
Employees
116↑ 2% increase
ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.
View company